Dow Water & Process Solutions' technologies to provide much-needed fresh water to French hospital in Kabul
Thanks to a partnership between Dow France & La Chaîne de l'Espoir, the company has developed a multi-technology treatment system to meet the water needs of the French Medical Institute for Mothers and Children.
Alexander Lane, commercial director EMEA, Dow Water & Process Solutions said: "We are extremely proud of how our technologies are making a difference in parts of the world where water scarcity is a challenge in both people's daily lives and all types of businesses. With the United Nations forecasting that 30% more water will be needed in 2030, it is vital that we develop tools to treat water and guarantee a more sustainable future for the planet".
"The extension of the IMFE is a challenge, because the hospital's need for drinking water is going to increase from 70 to 150 m3 per day. As the local authorities are not able to meet this need, La Chaîne de l'Espoir came to us to find a solution", says Blanca Salgado, a specialist water engineer at Dow Water & Process Solutions in France. The hospital has decided to source all of its needs from an independent well. However, the analysis of the water from the well has detected problems with pollution from nitrates, impurities and potential bacterial contamination.
"We have therefore designed an autonomous unit based on our ultra-filtration technology, which eliminates particles and bacteria from the water, and on our ion-exchange resins to treat nitrate pollution, which is particularly important for newborns", Blanca Salgado continues. The unit has been developed and deployed in Kabul by the French company ADH2OC. La Chaîne de l'Espoir Estimates that 250,000 people will be positively affected by this facility. Together with Dow France, the Fonds Suez Initiatives (Suez fund initiative) also supports this project.
The treatment unit has been designed to require minimum maintenance and ensure maximum reliability, in an area where access to maintenance products, spare parts and technical support is difficult.
"With cutting-edge technology and determination, it is possible to resolve the challenge of access to water in all regions of the world. Once it is launched, the hospital will benefit from 12 m3 per hour of drinking water, complying with WHO standards. This amazing success would not have been able to see the light of day without the commitment of all the partners in the project", says Pierre Burelli, President of Dow in France.
Since autumn 2016, the Mother and Child centre has enabled Afghan women to have access to quality gynaecological, prenatal and obstetric care, in a country where one woman dies every two hours from complications in pregnancy or labour.
About La Chaîne de l'Espoir and the French Medical Institute for Mothers and Children of Kabul
Chaired by Dr Eric Cheysson and created in 1994 by Professor Alain Deloche, La Chaîne de l'Espoir operates in more than 30 countries to offer access to care and education to the most disadvantaged children. Every year, more than 100,000 children benefit from its care programmes, including 5,000 who receive operations and 11,000 children who benefit from its education programmes.
In 2006, La Chaîne de l'Espoir created the French Medical Institute for Mothers and Children of Kabul (IMFE), which has saved the lives of thousands of Afghan children by giving them access to medicine and surgery which meets the highest international standards.
Equipped with advanced technology in terms of diagnostic and treatment equipment, the IMFE of Kabul is co-managed by La Chaîne de l'Espoir and the Aga Khan Development Network. In 2016, thanks to the support of the French Development Agency, the IMFE is acquiring a Mother and Child Centre, the only specialised centre in obstetric, at-risk pregnancy, neonatology and neonatal resuscitation care in Afghanistan.
To find out more and support La Chaîne de l'Espoir, click here: http://www.chainedelespoir.org/fr
About Dow in France
Dow started its business activities in France more than 50 years ago. Since then, the Group's presence has experienced steady growth. There are currently more than 1,300 staff, including more than 100 scientists, six industrial sites, a European research, development and technical support centre, and several administrative and commercial sites. To find out more, please visit our website:www.dow.fr
About The Dow Chemical Company
Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world's most challenging problems such as the need for clean water, clean energy generation and conservation, and increasing agricultural productivity. Dow's integrated, market-driven, industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 180 countries and in high-growth sectors such as packaging, electronics, water, coatings and agriculture. In 2015, Dow had annual sales of nearly $49 billion and employed approximately 49,000 people worldwide. The Company's more than 6,000 product families are manufactured at 179 sites in 35 countries across the globe. On June 1, 2016, Dow became the 100 percent owner of Dow Corning Corporation's silicones business, a global company with sales of greater than $4.5 billion in 2015, 25 manufacturing sites in 9 countries and approximately 10,000 employees worldwide. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.